Zomedica Corp. ZOMDF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 31.33% | 30.05% | 24.73% | 17.39% | 10.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.33% | 30.05% | 24.73% | 17.39% | 10.20% |
| Cost of Revenue | 48.37% | 46.93% | 42.07% | 26.26% | 15.80% |
| Gross Profit | 23.34% | 22.61% | 17.44% | 13.58% | 7.76% |
| SG&A Expenses | -15.18% | -11.44% | -9.68% | -8.14% | -9.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.74% | -5.07% | -3.03% | -2.83% | -6.18% |
| Operating Income | 44.24% | 35.85% | 25.94% | 18.58% | 17.62% |
| Income Before Tax | 80.97% | 77.61% | 77.70% | -72.78% | -36.63% |
| Income Tax Expenses | 50.88% | 42.66% | 59.38% | 50.09% | -331.71% |
| Earnings from Continuing Operations | 81.08% | 77.73% | 77.78% | -74.23% | -35.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.08% | 77.73% | 77.78% | -74.23% | -35.90% |
| EBIT | 44.24% | 35.85% | 25.94% | 18.58% | 17.62% |
| EBITDA | 56.90% | 45.30% | 31.93% | 23.94% | 23.06% |
| EPS Basic | 81.18% | 77.85% | 77.90% | -74.48% | -35.80% |
| Normalized Basic EPS | 44.02% | 34.76% | 24.08% | 16.50% | 15.98% |
| EPS Diluted | 81.18% | 77.85% | 77.90% | -74.48% | -35.80% |
| Normalized Diluted EPS | 44.02% | 34.76% | 24.08% | 16.50% | 15.98% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |